These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 38598952

  • 1. Passive assessment of tapping speed through smartphone is useful for monitoring multiple sclerosis.
    Chico-Garcia JL, Sainz-Amo R, Monreal E, Rodriguez-Jorge F, Sainz de la Maza S, Masjuan J, Villar LM, Costa-Frossard França L.
    Mult Scler Relat Disord; 2024 Jun; 86():105595. PubMed ID: 38598952
    [Abstract] [Full Text] [Related]

  • 2. Progression independent of relapse activity can be predicted by passively acquired tapping speed through a smartphone for 1 month: A prospective study.
    Chico-Garcia JL, Sainz Amo R, Monreal E, Sainz de la Maza S, Rodriguez Jorge F, Masjuan J, Costa-Frossard L, Villar LM.
    Mult Scler; 2024 Sep; 30(10):1341-1349. PubMed ID: 39246042
    [Abstract] [Full Text] [Related]

  • 3. Rapid foot-tapping but not hand-tapping ability is different between relapsing-remitting and progressive multiple sclerosis.
    Sato S, Lim J, Miehm JD, Buonaccorsi J, Rajala C, Khalighinejad F, Ionete C, Kent JA, van Emmerik REA.
    Mult Scler Relat Disord; 2020 Jun; 41():102031. PubMed ID: 32172213
    [Abstract] [Full Text] [Related]

  • 4. Clinical characterization of long-term multiple sclerosis (COLuMbus) patients in Argentina: A cross-sectional non-interventional study.
    Deri N, Barboza A, Vrech C, Rey R, Burgos M, Fiol M, CalvoVildoso C, Patrucco L, Jose G, Aliberti P, Chirico D, Federico MB, Seifer G, Piedrabuena R.
    Mult Scler Relat Disord; 2024 Mar; 83():105421. PubMed ID: 38244525
    [Abstract] [Full Text] [Related]

  • 5. Continuous daily assessment of multiple sclerosis disability using remote step count monitoring.
    Block VJ, Lizée A, Crabtree-Hartman E, Bevan CJ, Graves JS, Bove R, Green AJ, Nourbakhsh B, Tremblay M, Gourraud PA, Ng MY, Pletcher MJ, Olgin JE, Marcus GM, Allen DD, Cree BA, Gelfand JM.
    J Neurol; 2017 Feb; 264(2):316-326. PubMed ID: 27896433
    [Abstract] [Full Text] [Related]

  • 6. Spinal cord grey matter abnormalities are associated with secondary progression and physical disability in multiple sclerosis.
    Kearney H, Schneider T, Yiannakas MC, Altmann DR, Wheeler-Kingshott CA, Ciccarelli O, Miller DH.
    J Neurol Neurosurg Psychiatry; 2015 Jun; 86(6):608-14. PubMed ID: 25097217
    [Abstract] [Full Text] [Related]

  • 7. Modelling disease progression in relapsing-remitting onset multiple sclerosis using multilevel models applied to longitudinal data from two natural history cohorts and one treated cohort.
    Tilling K, Lawton M, Robertson N, Tremlett H, Zhu F, Harding K, Oger J, Ben-Shlomo Y.
    Health Technol Assess; 2016 Oct; 20(81):1-48. PubMed ID: 27817792
    [Abstract] [Full Text] [Related]

  • 8. [Information processing speed and influential factors in multiple sclerosis].
    Zhang ML, Xu EH, Dong HQ, Zhang JW.
    Zhonghua Yi Xue Za Zhi; 2016 Apr 19; 96(15):1173-7. PubMed ID: 27117362
    [Abstract] [Full Text] [Related]

  • 9. Natural history of multiple sclerosis: a unifying concept.
    Confavreux C, Vukusic S.
    Brain; 2006 Mar 19; 129(Pt 3):606-16. PubMed ID: 16415308
    [Abstract] [Full Text] [Related]

  • 10. Quantitative measures detect sensory and motor impairments in multiple sclerosis.
    Newsome SD, Wang JI, Kang JY, Calabresi PA, Zackowski KM.
    J Neurol Sci; 2011 Jun 15; 305(1-2):103-11. PubMed ID: 21458828
    [Abstract] [Full Text] [Related]

  • 11. Cognitive impairment in a population-based study of patients with multiple sclerosis: differences between late relapsing-remitting, secondary progressive and primary progressive multiple sclerosis.
    Planche V, Gibelin M, Cregut D, Pereira B, Clavelou P.
    Eur J Neurol; 2016 Feb 15; 23(2):282-9. PubMed ID: 25903918
    [Abstract] [Full Text] [Related]

  • 12. Early Clinical Features, Time to Secondary Progression, and Disability Milestones in Polish Multiple Sclerosis Patients.
    Rzepiński Ł, Zawadka-Kunikowska M, Maciejek Z, Newton JL, Zalewski P.
    Medicina (Kaunas); 2019 May 31; 55(6):. PubMed ID: 31159275
    [Abstract] [Full Text] [Related]

  • 13. Kurtzke scales revisited: the application of psychometric methods to clinical intuition.
    Hobart J, Freeman J, Thompson A.
    Brain; 2000 May 31; 123 ( Pt 5)():1027-40. PubMed ID: 10775547
    [Abstract] [Full Text] [Related]

  • 14. Natural history of secondary-progressive multiple sclerosis.
    Tremlett H, Yinshan Zhao, Devonshire V.
    Mult Scler; 2008 Apr 31; 14(3):314-24. PubMed ID: 18208898
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the timed 25-foot and the 100-meter walk as performance measures in multiple sclerosis.
    Phan-Ba R, Pace A, Calay P, Grodent P, Douchamps F, Hyde R, Hotermans C, Delvaux V, Hansen I, Moonen G, Belachew S.
    Neurorehabil Neural Repair; 2011 Sep 31; 25(7):672-9. PubMed ID: 21436388
    [Abstract] [Full Text] [Related]

  • 16. Olfactory dysfunction in multiple sclerosis: association with secondary progression.
    Silva AM, Santos E, Moreira I, Bettencourt A, Coutinho E, Gonçalves A, Pinto C, Montalban X, Cavaco S.
    Mult Scler; 2012 May 31; 18(5):616-21. PubMed ID: 22020420
    [Abstract] [Full Text] [Related]

  • 17. Serious infections in patients with relapsing and progressive forms of multiple sclerosis: A German claims data study.
    Knapp R, Hardtstock F, Krieger J, Wilke T, Maywald U, Chognot C, Muros-Le Rouzic E, Craveiro L.
    Mult Scler Relat Disord; 2022 Dec 31; 68():104245. PubMed ID: 36306609
    [Abstract] [Full Text] [Related]

  • 18. Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.
    Tsagkas C, Naegelin Y, Amann M, Papadopoulou A, Barro C, Chakravarty MM, Gaetano L, Wuerfel J, Kappos L, Kuhle J, Granziera C, Sprenger T, Magon S, Parmar K.
    Eur J Neurol; 2021 Dec 31; 28(12):4153-4166. PubMed ID: 34487400
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls.
    Goldman MD, Marrie RA, Cohen JA.
    Mult Scler; 2008 Apr 31; 14(3):383-90. PubMed ID: 17942508
    [Abstract] [Full Text] [Related]

  • 20. Investigation of outer cortical magnetisation transfer ratio abnormalities in multiple sclerosis clinical subgroups.
    Samson RS, Cardoso MJ, Muhlert N, Sethi V, Wheeler-Kingshott CA, Ron M, Ourselin S, Miller DH, Chard DT.
    Mult Scler; 2014 Sep 31; 20(10):1322-30. PubMed ID: 24552746
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.